RxDoctor Payments Data

Meredith Tittsworth

Women's Health · Fairchild Afb, WANPI 1265764799

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 38 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 23.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $228 and has fallen 73.2% since, to $61 in 2025.

$744in general payments, 2019–2025

Across 38 payments — averaging $19.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exeltis, USA Inc.$175
  • Avion Pharmaceuticals$97
  • AbbVie$88
  • Organon$68
  • Aspira Women's Health Inc$54
  • Mylan Pharmaceuticals Inc.$36
  • plus $225 from 10 others

What the payments were for

  • Food & beverage$744100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$744 in reported general payments places this provider in the 75th percentile of 101 women's health providers in Washington.

See all women's health providers in Washington

Medicare billing

Part B allowed, 2024
$1,550
Medicare patients
17
Services billed
24

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Metronidazole30$173

Paid to pharmacies, not to this prescriber.

Other women's health in Fairchild Afb

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →